Atom | CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

Funder: National Institutes of Health

Due Dates: September 17, 2025 (Letter of Intent) | October 17, 2025 (Application) | September 16, 2026 (Letter of Intent) | October 16, 2026 (Application)

Funding Amounts: Up to $300,000 direct costs per year, for up to 3 years; NIH anticipates up to 4 awards in FY 2026.

Summary: Supports basic research on chemical threats with primary or secondary effects on the nervous system, aiming to elucidate mechanisms of toxicity and identify new therapeutic targets.

Key Information: Clinical trials are not allowed; research must focus on acute (not chronic) exposures and address chemicals designated as Chemicals of Concern (CoC) with neurological effects.

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing